Impact of a Helmet Distribution Program in the Pediatric Emergency Department.

OBJECTIVE: Bicycle helmet use has repeatedly been shown to protect riders from serious injury. Despite this, a majority of children and adolescents do not regularly wear helmets. Our primary objective was to determine if an emergency department (ED)-based helmet distribution program could increase the amount of time children report wearing helmets. METHODS: This was a prospective cohort study of children aged 3 to 17 years presenting to the ED of an urban, tertiary care hospital. Participants were surveyed on their helmet use habits and perceptions regarding the efficacy and importance of helmets. Participants then received a bicycle helmet along with safety counseling in the ED and bicycle safety handouts provided by the American Academy of Pediatrics. Participants were contacted for follow-up 8 weeks after enrollment. RESULTS: We enrolled a total of 94 patients. Post-intervention surveys were obtained from 47% of participants. Our helmet program resulted in a statistically significant increase in the amount of time children reported wearing bicycle helmets. Prior to ED intervention, 48% of participants reported wearing a helmet "most of the time" or "all of the time." After participating, 86% of participants indicated that they wore a helmet "most of the time" or "all of the time." Participants indicated a variety of reasons for not wearing helmets. Of all patients contacted for follow-up, 16% indicated that they were involved in an accident after participating where the helmet they were given prevented a head injury. CONCLUSIONS: Helmet distribution programs based in the pediatric ED increase rates of bicycle helmet usage among pediatric patients. Additional study is needed to determine effect on head injury prevention.

Electrolyte disturbances in patients hospitalized for COVID-19 infection: An observational study.

There are multiple mechanisms by which The Coronavirus-19 (COVID-19) infection can cause electrolyte abnormalities, which may not be the case for bacterial causes of pneumonia. This study aimed to assess the differences in electrolyte levels between patients suffering from COVID-19 and bacterial pneumonia. This is an original, retrospective study. Two cohorts of hospitalized patients were included, 1 suffering from COVID-19 and the other from bacterial pneumonia. Their day 1 and day 3 levels of sodium, potassium, magnesium, and phosphorus, as well as their outcomes, were extracted from the charts. Statistical analysis was subsequently performed. Mean admission levels of sodium, potassium, phosphorus, and magnesium were 135.64 ±â€…6.13, 4.38 ±â€…0.69, 3.53 ±â€…0.69, and 2.03 ±â€…0.51, respectively. The mean day 3 levels of these electrolytes were 138.3 ±â€…5.06, 4.18 ±â€…0.59, 3.578 ±â€…0.59, and 2.11 ±â€…0.64, respectively. Patients suffering from bacterial pneumonia were significantly older (N = 219, mean = 64.88 ±â€…15.99) than patients with COVID-19 pneumonia (N = 240, mean = 57.63 ±â€…17.87). Bacterial pneumonia group had significantly higher serum potassium (N = 211, mean = 4.51 ±â€…0.76), and magnesium (N = 115, mean = 2.12 ±â€…0.60) levels compared to COVID-19 group (N = 227, mean = 4.254 ±â€…0.60 for potassium and N = 118, mean = 1.933 ±â€…0.38 for magnesium). Only magnesium was significantly higher among day 3 electrolytes in the bacterial pneumonia group. No significant association between electrolyte levels and outcomes was seen. We found that COVID-19 patients had lower potassium and magnesium levels on admission, possibly due to the effect of COVID-19 on the renin-angiotensin-aldosterone system as well as patient characteristics and management. We did not find enough evidence to recommend using electrolyte levels as a determinator of prognosis, but more research is needed.

High-flow nasal cannula during pulmonary rehabilitation for people with chronic obstructive pulmonary disease: A systematic review and meta-analysis.

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an increasingly concerning global public health issue due to its high burden of morbidity and mortality. Pulmonary rehabilitation (PR) is a comprehensive intervention to improve patients' physical and psychological conditions, commonly involving oxygen supplementation. The potential benefits of high-flow nasal cannula (HFNC) have recently sparked interest as oxygen therapy. In this context, this study aims to assess the effects of HFNC during the exercise training component of a PR program in people with COPD. METHODS: Systematic review (CRD42022330929). We included randomised controlled trials (RCTs), including crossover RCTs with adults with stable COPD. We included trials using oxygen therapy with HFNC during the exercise training component of a PR programme. PRIMARY OUTCOMES: disease-specific health-related quality of life (HRQoL), exercise capacity (EC) and adverse events. SECONDARY OUTCOMES: treatment adherence, breathlessness and future exacerbations. RESULTS: We included five studies with 300 participants with moderate to severe COPD. The certainty of the evidence was primarily low or very low for all outcomes of interest due to risk of bias, inconsistency or imprecision. HFNC has little to no difference in HRQoL (4 studies, 129 participants, MD 0.17, 95% CI -1.20 to 1.54; I2 50%). HFNC may result in little to no difference in EC (3 studies, 212 participants, mean difference 18.73, 95% CI -20.49 to 28.94; I2 56%), and we are uncertain about the effect of HFNC on breathlessness (4 studies; 244 participants, MD of -0.07, 95% CI -0.4 to 0.26; I2 63%). Only one study with 44 participants reported a participant's withdrawal because of progressive dyspnoea during lower limb exercise. CONCLUSIONS: We are uncertain about the effect of HFNC during the exercise component of a PR programme in HRQoL, EC or dyspnoea compared to usual care or conventional supplementary oxygen. Non-domiciliary oxygen patients showed improvements in HRQoL, EC and dyspnoea.

Valor pronóstico de la hipoglucemia hospitalaria / Prognostic value of hospital hypoglycemia

Resumen Introducción: La hipoglucemia hospitalaria (HH) es un problema importante ya que se vincula a muerte hospitalaria, estadía prolongada y mayores costos, en personas con y sin diabetes, en área crítica y sala general, sobre todo en los casos de hipoglucemia grave. El objetivo de nuestro trabajo fue comparar la mortalidad hospitalaria, pase a área crítica y tiempo de internación en adultos con HH, según la gravedad de la misma. Métodos: Se realizó un estudio de cohorte retrospectiva en pacientes adultos interna dos con hipoglucemia en el Hospital Italiano de Buenos Aires entre 2013 y 2018. Se definieron tres grupos de hipoglucemia: leve (glucemia entre 70 y 54 mg/dl), grave (glucemia < 54 mg/dl ≥ 40 mg/dl) y crítica (glucemia < 40mg/dl). Resultados: Un total de 5994 pacientes tuvieron HH, la mayoría presentó hipoglucemia leve (72%). La hipoglucemia grave y la crítica, comparadas con la hipoglucemia leve se asociaron a una mayor mortalidad: OR 2.6 (IC95% 2.2-3.1) y 4.2 (IC95% 3.5-5.0) respectivamente; y a mayor internación en áreas de cuidados críticos: OR 1.6 (IC95% 1.4-1.9) y 3.2 (IC95% 2.6-4.0) respectivamente. No hubo diferencias en el tiempo de internación. Discusión: Esta información aporta evidencia en nuestro país, sobre el valor pronóstico de la hipo glucemia, cuya mayor gravedad se asocia a mayor internación en áreas críticas y mayor mortalidad hospitalaria.

Abstract Background: Hospital hypoglycemia (HH) is an important problem since it is linked to hospital death, prolonged stay and higher costs, both in people with and without diabetes, in the critical area and general ward, especially in cases of severe hypoglycemia. The objective of our work was to compare hospital mortality, transfer to the critical area and hospitalization periods in adults with HH according to its severity. Methods: We conducted a retrospective cohort of adults hospitalized with hypoglycemia at the Hospital Italiano de Buenos Aires between 2013 and 2018. Three groups of hypoglycemia were defined: mild (glycemia between 70 and 54 mg/dl), severe (glycemia < 54 mg/dl and ≥ 40 mg/dl) and critical (glycemia<40mg/dl). Results: A total of 5994 patients had HH, the majority presented mild hypoglycemia (72%). Severe and critical hypoglycemia, compared with mild hypo glycemia, were associated with higher mortality: OR 2.6 (95%CI 2.2-3.1) and 4.2 (95%CI 3.5-5.0) respectively; and increased hospitalization in critical care areas: OR 1.6 (95%CI 1.4-1.9) and 3.2 (95%CI 2.6-4.0) respectively. There were no differences in length of stay. Discussion: This information provides, in our country, evidence on the prognostic value of hypoglycemia, whose greater severity is associated with increased hospitalization in critical areas and higher hospital mortality.

Factores de riesgo y secuelas reproductivas asociados a la infección por Chlamydia trachomatis en mujeres infértiles / Risk factors and reproductive sequelae associated with Chlamydia trachomatis infection in infertile women

OBJETIVO: Comparar la información clínica y el estilo de vida sexual en dos grupos de mujeres con y sin infección por Chlamydia trachomatis que asisten a la clínica de infertilidad del Instituto Nacional de Perinatología, de la Ciudad de México. MATERIAL Y MÉTODOS: De febrero a noviembre de 1998, se realizó un estudio prospectivo en pacientes con diagnóstico de infertilidad. En el estudio se incluyó a pacientes con diagnóstico de infertilidad, tratados en el Instituto Nacional de Perinatologia, de la Ciudad de México, durante 1988. Las muestras endocervicales de 309 mujeres, que incluyeron a 77 con infección y a 232 sin infección, fueron examinadas para Chlamydia trachomatis, usando inmunofluorescencia directa. Los cultivos vaginales fueron obtenidos antes de iniciar el tratamiento. También se investigó la presencia de otros agentes infecciosos de transmisión sexual y la información demográfica, de conducta sexual, histórica y clínica fue recopilada de cada paciente. Los datos clínicos y ginecológicos de ambos grupos fueron comparados por ji2. La magnitud de las asociaciones fueron establecidas por razón de momios en análisis bivariados. Se realizó un análisis de regresión logística para establecer los efectos confusores en relación con los factores analizados. Las diferencias fueron consideradas estadísticamente significativas si p<0.05. RESULTADOS: Para el estudio 309 mujeres fueron elegibles, 77 (24.9 por ciento) cursaron con infección por C trachomatis, de éstas, 70 (90.9 por ciento) mencionaron tener un compañero sexual, 58 (75.3 por ciento) estaban casadas, 19 (24.7 por ciento) eran solteras o vivían en concubinato, 15 (19.5 por ciento) utilizaron el dispositivo intrauterino para el control de la natalidad, 41 (53.2 por ciento) presentaron coinfección con otros agentes infecciosos de transmisión sexual, y 19 (24.7 por ciento) cursaron con infertilidad por obstrucción tubárica. Las secuelas reproductivas observadas en las pacientes con infección por C trachomatis mostraron que 24 (31.2 por ciento) tuvieron abortos, 50 (64.9 por ciento), gestaciones previas, 26 (33.8 por ciento) anormalidades en el cérvix y 50 (64.9 por ciento) secreciones vaginales purulentas, con dolor (18.1 por ciento). El análisis bivariado mostró que los factores de riesgo asociados significativamente con la infección por C trachomatis fueron la presencia de un compañero sexual (OR= 2.96, IC 95 por ciento 1.22-7.5, p=0.008), concubinato (RM=3.68, p=0.03) y uso de...

Induction of tumor necrosis factor-alpha by cefodizime in U-937 cells

La cefodizima presenta efectos moduladores sobre la liberación de diversas citocinas. En esta investigación se determinó la actividad moduladora de este antibiótico sobre la producción del factor de necrosis tumoral (TNF) en una línea de células monocitica humana U-937. La medición de TNF se realizó mediante las pruebas de ELISA y bioensayo de citotoxicidad empleando células L-929. Los resultados mostraron que la cefodizima por si sola indujo la producción de TNF sobre las células U-937, sin embargo, la adición de LPS condujo a una disminución en la liberación de esta citocina (p<0.05). Por otro lado la combinación cefodizima-PMA tuvo un efecto sinérgico (p<0.05), sin embargo, la adición de LPS a esta combinación causó una disminución de la producción de TNF (p<0.05). Con estos resultados observamos que la cefodizima regula la producción de TNF en las células U-937, produciendo una menor concentración de TNF con la adición de LPS.

Tumor necrosis factor in peritoneal fluid from asymptomatic infertile women

Background. Tumor necrosis factor-Ó (TNF-Ó) is a cytokine that can be found in the peritoneal fluid (PF) of patients with endometriosis and pelvic inflammatory disease (PID) as a response to inflammatory disorders and infections. The cytotoxic effect of this cytokine could be a factor participating in the pathology of various gynecological diseases, and could also be accountable for the high immunological response and demage to the tubal epithelium. The objective of this study was ato establish the presence of TNF-Ó in asymptomatic infertility and its association with various isolated bacteria. Methods. Ten milliliters of PF were collected from each of 73 patients by means of laparoscopy and cultured in synthetic medium and McCoy cells for the isolation of aerobic and anaerobic bacteria, as well as for Chlamydia trachomatis. The activity of TNF-Ó was determined by means of a bioassay using L-929 cells. Results. Forty-three parcent of the PFs showed positive TNF-Ó activity, while the laparoscopic evaluation showed that 32 patients had Fallopian tube occlusion (FTO), 7 had endometriosis, 30 had PID. and 4 had myomas and adhesions. TNF-Ó activity was found to be high in FTO patients (P<0.05). Positive cultures were found in 50.7 percent of patients; of these, 31.5 percent had PID (p< 0.05), and only 20.5 percent of positive cultures were TNF-Ó positive. Chlamydia trachomatis (16 percent) was the most frequently isolated bacteria in these patients. Conclusions. The detection of TNF-Ó could be useful in the diagnosis of active infectious and inflammatory diseases in asymptomatic infertile patients